chrisvoncsefalvay/vaers-outcomes huggingface dataset:
dies of a double heart attack during a game; Initial information received on 27-Jan-2022 regarding an unsolicited valid Social Media serious case received from a consumer/non-hcp.  This case involves a 17 years old and unknown gender patient who dies of a double heart attack during a game while receiving vaccine Influenza Vaccine.   The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received suspect influenza vaccine (strength, formulation, dose and frequency: unknown) produced by unknown manufacturer (lot number and expiry date: not reported) via unknown route in unknown administration site as prophylactic vaccination.  The consumer commented that the list went on and on, and on and it was happening everywhere and was not normal. On an unknown date the patient developed a serious dies of a double heart attack during a game (myocardial infarction) (unknown latency) following the administration of Influenza Vaccine. This event was assessed as medically significant and was leading to death. No autopsy was done. The cause of death was reported as Heart attack.  Final diagnosis was (fatal) dies of a double heart attack during a game.  Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the event (dies of a double heart attack during a game).  At time of reporting, the outcome was Fatal for the event dies of a double heart attack during a game.; Sender's Comments: Sanofi company comment dated 02-Feb-2022: This case concerns a 17 years old adolescent patient of unknown gender who died due to heart attack during the game, after vaccination with vaccine Influenza Vaccine. Time to onset of the event is unknown. Information regarding condition at the time of vaccination, medical history, concomitant medication, autopsy findings would be needed  to rule out the alternative etiology. Based on the reported information, the role of an individual vaccine cannot be assessed.; Reported Cause(s) of Death: Double heart attack
Disoriented, dizzy, headache, body aches, extremely sore and fever all day and over night of 101-103 degrees.
My son was awaken with headache, fever, body aches and chills. I gave him Tylenol in the morning and Motrin at 3 pm. He has very bad chills and can't stop shaking. I called the ER and was told to call my primary physician. It's the weekend and I can't get a hold of her.
sz & low sodium in 18hrs;acts fussy,cry,irritable for weeks;h/a for weeks;inappropriate ADH secretion for months
Patient presented to the ED one week after his 2nd dose of the COVID-19  vaccine with a couple of days of worsening shortness of breath. He reported the shortness of breath was present at rest and with activity. The patient reports that he also had a productive cough and right sided chest pain present for the last several weeks. He reports this has been constant with no modifying factors.
Client experienced minor chest pain, SOB, stiff neck, muscle pain 4 days after receiving TDaP, MENACTRA, YF, Hep A (HAVRIX) and TYPOHID (INJ). Went to ER, EKG was normal.
I think the injection may have been subcutaneous and not IM. Is there a test to find out if it was effective? I did not feel the shot AT ALL, and now four days later my arm is hot and swollen on the side closer to the body.
Pneumonia; Pneumonia; This is a spontaneous report from a contactable physician via Pfizer sales representative who reported same event for two different patients. This was the 2nd of 2 reports.  An elderly male patient received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13), and pneumococcal vaccine polysacch 23v (PNEUMOVAX), both at single dose via an unspecified route of administration on an unspecified date for immunisation. The patient medical history and concomitant medications were not reported. The patient experienced pneumonia on an unspecified date with outcome of unknown. The patient was hospitalized due to the event. Information on the batch number has been requested.; Sender's Comments: Based on the information currently available, a lack of efficacy with pneumococcal 13-valent conjugate vaccine in this patient cannot be completely excluded.  Further information like confirmative pathological/serotype results are needed for full medical assessment.,Linked Report(s) : US-PFIZER INC-2019241946 same reporter, different patient, same product and event
ALL SORTS OF COMPLICATIONS; This spontaneous report received from a consumer via a company representative concerned a 26 year old of unspecified sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced all sorts of complications. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of all sorts of complications was not reported. This report was non-serious.
this is 1 of 5 employees @ this site to have an unspecified adverse exp p/vax;
Vaccine provided past the beyond-use-date of 01/02/2022. Incident report submitted.
Lost his sense of taste/ could not taste his Budweiser; Lost his sense of smell; Tested positive for COVID; temperature of 104.8/ temperature was 100.8/  temperature was 101.2; feeling bad; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (feeling bad), AGEUSIA (Lost his sense of taste/ could not taste his Budweiser), ANOSMIA (Lost his sense of smell), COVID-19 (Tested positive for COVID) and PYREXIA (temperature of 104.8/ temperature was 100.8/  temperature was 101.2) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included AMLODIPINE and LISINOPRIL for an unknown indication.   On 09-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jul-2021, the patient experienced FEELING ABNORMAL (feeling bad). On 24-Jul-2021, the patient experienced PYREXIA (temperature of 104.8/ temperature was 100.8/  temperature was 101.2). On 26-Jul-2021, the patient experienced COVID-19 (Tested positive for COVID). On an unknown date, the patient experienced AGEUSIA (Lost his sense of taste/ could not taste his Budweiser) and ANOSMIA (Lost his sense of smell). On 04-Aug-2021, COVID-19 (Tested positive for COVID) had resolved. At the time of the report, FEELING ABNORMAL (feeling bad), AGEUSIA (Lost his sense of taste/ could not taste his Budweiser), ANOSMIA (Lost his sense of smell) and PYREXIA (temperature of 104.8/ temperature was 100.8/  temperature was 101.2) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Jul-2021, Body temperature: 104.8 (High) 104.8. On 25-Jul-2021, Body temperature: 101.2 (High) 101.2. On 26-Jul-2021, Body temperature: 100.8 (High) 100.8. On 26-Jul-2021, SARS-CoV-2 test: postive (Positive) postive. On 04-Aug-2021, SARS-CoV-2 test: negative (Negative) negative.         No concomitant medications were reported by the reporter.  No Treatment information was provided by the reporter.
Woke up at 0500 with extreme headache and took Ibuprofen for relief, ate yogurt and cereal bar and departed for work. At work headache became more vigorous and became lightheaded and nausea went back to classroom and walked into room and blacked out on floor. Blacked out for approx. 2 minutes and started to come to with blurriness in peripheral, nausea set in strong...Medics arrived on scene and took BP which was 180 over 120 (never been that high). Was taken to Hospital via ambulance, Labs taken, CT of head and chest and pain meds for headache administered.   Course of time of approx. 5 hrs, doctor stated possible migraine triggered episode and was discharged. (Never had migraines before)
This case was reported by a physician and described the occurrence of hepatitis B antigen positive in an infant subject of unspecified gender who was vaccinated with ENGERIX B (GlaxoSmithKline). On an unspecified date the subject received unspecified dose of ENGERIX B (unknown). One day after vaccination with ENGERIX B, the subject was tested for hepatitis B antigen and the result was positive. At the time of reporting the outcome of the event was unspecified. No further details were provided. It was reported that this event occurred in 4 infant subjects from different hospital facilities. Linked cases include A0942894A, A0942898A and A0942899A.
Received second dose 37 days after first dose; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received second dose 37 days after first dose) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002C21A and 026B21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 on 13-Jan-2021. Concurrent medical conditions included Allergy to animals (Allergy to horses), Allergy to animals (Allergy to cats), Allergy to animals (Allergy to dogs) and Grass allergy.   On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-May-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received second dose 37 days after first dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received second dose 37 days after first dose) outcome was unknown.            No concomitant product was provided by the reporter.  No treatment medication was provided.   This case was linked to MOD-2022-564413 (Patient Link).
This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Had COVID Disease), PALPITATIONS (Palpitations) and PRODUCT DOSE OMISSION ISSUE (missed dose) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination. The patient's past medical history included COVID-19. On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced PALPITATIONS (Palpitations). On an unknown date, the patient experienced COVID-19 (Had COVID Disease) and PRODUCT DOSE OMISSION ISSUE (missed dose). At the time of the report, COVID-19 (Had COVID Disease) and PALPITATIONS (Palpitations) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (missed dose) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available):- In February 2021, COVID-19: positive (Positive) Had COVID disease. On an unknown date, Echocardiogram: normal (normal) normal. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Patient received IV fluids as treatment. Patient reported that she experienced heart palpitations 1.5 hours after receiving the vaccine, Patient reported cardiac lab data as ECG, cardiac test, cardiac enzymes. Patient reported that Echo was normal. Most recent FOLLOW-UP information incorporated above includes: On 26-Aug-2021: Event updated.
Pt described pain and swelling in the arm. Initially a lump. Reports swelling increased to include shoulder. Pt was referred to PCP for evaluation. RPh calling later today to follow up on outcome.
As previously mentioned I had migraines before the vaccine, but after the vaccine I had a 4 migraines in 5 days with no response to my usual medications that I take for them.   I also would like to report an inconsistency in my menstruation cycle- it was very regular/consistent until September, the month after vaccinating. My period lasted 16 days rather than the usual 5-7, and I had various side effects with that- cramping, mood swings, lethargy- that I don?t usually experience.
I got the first SHINGRIX shot and within 24 hours my whole arm was red and swollen. I had chest congestion and my whole upper body, including face broke out in hives.
about 2 hrs p/vax pt had a t102.7; next morning the temp was the same; pt was given Motrin; pt slept alot, wanted to be held & had a poor appetite; seen by MD; 1SEP95 had ear infect
fever, dizzy, headache, severe pain throughout body for 24 hours, screaming pain could feel vaccine going through entire body tiredness hoarseness, heavy breathing 6 weeks after vaccine
hardness and knot at injection site; hardness and knot at injection site; Itching; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ABSCESS (hardness and knot at injection site), MUSCULOSKELETAL STIFFNESS (hardness and knot at injection site) and PRURITUS (Itching) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 11-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced VACCINATION SITE ABSCESS (hardness and knot at injection site), MUSCULOSKELETAL STIFFNESS (hardness and knot at injection site) and PRURITUS (Itching). At the time of the report, VACCINATION SITE ABSCESS (hardness and knot at injection site), MUSCULOSKELETAL STIFFNESS (hardness and knot at injection site) and PRURITUS (Itching) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Onset of anxious feelings, feeling flushed, and warm feelings on side of left neck and shoulder (across clavicle), associated with "a little bit of numbness" - same side as vaccination placed - approximately 25 minutes after receiving vaccine.   Did take antihypertensive today.  Did have significant side effects (dizziness, nausea, vomiting, myalgias) 4 hours post-dose after 1st Covid vaccine, no allergic reaction.  No dysphagia, dyspnea, SOB.  No rash or swelling of face/mouth/neck. VS @ 11:55:  BP146/98, P 70, SpO2: 99%, resp. unlabored.  Drank some water, elevated feet, continues observation. VS @ 11:58: BP 155/100, P 77, SpO2 99%.  Feeling "a little better". VS @ 12:05:  P 77, SpO2 99%.  Reports she feels "fine", symptoms resolved. Home at 12:15 with complete symptom resolution.  Instructions re: side effect management/self-care, when to call ED given.
Shingles flare up; Shingles flare up; This is a spontaneous report from a contactable nurse (patient). A 31-year-old male patient received his second dose of bnt162b2 (BNT162B2 reported as PFIZER COVID VACCINE; lot number: EL9262; expiration date: unknown) at 31-year-old vaccination age via an unspecified route of administration in the right deltoid on 18Feb2021 9:00 AM as a single dose to protect self (covid-19 immunization). Medical history included chicken pox virus as a kid and shingles. The patient has no family medical history. There were no concomitant medications. Historical vaccination included varicella zoster vaccine (CHICKENPOX VACCINE) for vaccination for chicken pox and received his first dose of bnt162b2 (BNT162B2 reported as PFIZER COVID VACCINE; lot number: EL3246) at unknown vaccination age via an unspecified route of administration in the left deltoid on an unspecified date as a single dose to protect self (covid-19 immunization). The patient received the vaccine in a hospital and did not receive other vaccines administered on same date of Pfizer suspect. The patient did not have prior vaccinations within 4 weeks. The patient reported that he just got a flare up of shingles on 28Feb2021 and doesn't know if it is related or not to the covid vaccination he took. The patient reported that he did nothing unusual in the last 14 days. Doesn't know if that is something to report to see if there was any trending. The patient inquired if a shingles flare-up has happened before after the COVID vaccine. He got the vaccine ten days before (18Feb2021) the shingles flare up started. He added that it is on right side of torso in the thorax area and goes from midline abdomen all the way to midline on his back on the right side. The adverse event required urgent care visit (emergency room visit). The nurse considered the event serious. The patient did not have relevant tests and was only clinically diagnosed with a shingles flare up. The outcome of the events was not recovered.; Sender's Comments: Based on the information currently available, a possible contributory role of the suspect drug to the reported event "Shingles flare up" cannot be completely excluded based on temporal association.   The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identifies as part of this review, as well as any appropriate action in response, will be promptly notifies to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Information has been received from a registered pharmacist concerning a patient who on approximately 20-OCT-2010, with last 24-48 hours was vaccinated with a dose of PNEUMOVAX 23 (dose, route and lot# not reported). The patient developed a red swollen arm from shoulder to elbow after administration of PNEUMOVAX 23. The patient sought unspecified medical attention. At the time of this report, the patient's outcome was unknown. Additional information has been requested.
The day after the shot I was running a fever of over 104 and had chills, body aches, coughing, incontinence, and I lost my voice. I didn't get my voice back for 6 weeks. I had to get steroids to get it back.
This case was reported by a consumer via call center representative and described the occurrence of extra dose administered in a elderly female patient who received Herpes zoster (shingrix) for prophylaxis. Previously administered products included shingrix (received 1st dose on 13th December 2018) and shingrix (received 2nd dose on an unknown date). On an unknown date, the patient received the 3rd dose of shingrix. On an unknown date, unknown after receiving shingrix, the patient experienced extra dose administered. On an unknown date, the outcome of the extra dose administered was unknown. Additional details were provided as follows: The case was self reported by the patient. The age at vaccination was unknown. The reporter stated that, she returned to the pharmacy and received her second dose, but the pharmacy told her to consider it as first dose. The reporter did not know why she was told this information. The reporter also had a third dose of shingrix as directed by the pharmacy, which led to extra dose administered. The reporter had no information regarding the dates of 2nd and 3rd dose of shingrix. The reporter consented to follow up.
SOB, cough and weakness. Feeling ill for about 1 week with cough, weakness and general malaise.  So weak that he fell at home and hit his head.
On 06/11/2021 I had some blood work done because my white blood cell count was too high and my doctor wanted me to have a bone marrow biopsy, they removed a piece of my hip bone, and they said I had Smoldering multiple myeloma, which means I have some abnormal cells that could or could not turn into multiple myeloma.
Admitted to the hospital on 6/26/22-6/30/22 for wound infection and pain of RLE. Has Hx of PAD, AICD, CHF, DVT, AKA, MRSA, Hep C. Covid virus was detected on admission. Hospital course was for treating cellulitis of RLE and sent home with oral antibiotics. Vascular surgery and wound care was consulted
Increase in Anxiety, up and down mood swings?- increased crying and tight chest due to the anxiety, anxiety still high, going to make appt with doctor
Left arm swollen, red, feverish area at injection site and surrounding area. Was seen at ER on 2/25/03 at 7:00 PM. Was told to give Benadryl po and Tylenol/Advil prn. Apply cold cloths to area. Did have fever of 101.6 on 2/26/03 at 7 AM. Responded to children's Advil.
After 2nd vaccine shot I had what I read were normal side effects such as soreness and aches, especially on left side of upper body.  Then 2 days later I got a bad rash on my back and on my left side that was itchy and kind of painful. It continues?
Patient's friend stated patient had gone to the emergency room and found to have a brain bleed. She stated the Doctor told her to report to vaccination site.
My son was wrongly given a Hepatitis A shot instead of Hep B shot at his one month doctor's well check. Fortunately, he had no reaction but could this shot cause harm to him in the future as there are no studies for children under 12 months receiving this shot? I even contacted Merck the manufacturer and they can't tell me anything. Feeling worried.
A physician reported that a 17 month old male received his 2nd injection of Prevnar on 9/25/00. One day, post vax, the child was seen in the clinic after developing angioedema and urticaria. The child recovered. Both the investigator and the medical monitor considered the events to be "possibly" related to Prevnar administration.
Provider HPI: "Presented to the emergency department by ambulance for an evaluation of allergic reaction.  The patient had the COVID-19 vaccination at approximately 9:30 AM.  Over the last few hours the patient started to notice allergic reaction including redness and itchiness across his chest.  The patient denies having any chest pain or difficulty breathing.  He has no swelling in his oropharynx.  He complains of nausea.  He denies having any chest pain.  He denies having any lower extremity swelling." Provider physical examination: "The area of the injection noted over the right deltoid is clear.  There is no erythema or swelling.  There is erythema over the anterior neck.  This has the appearance of a coalescing hives."
Severe burning and pins and needles in feet evening of 9/28/21 starting at 5pm. Now morning of 9/29/21 at 7am has spread to calf muscles. Very painful.
Patient reported to me on 11 May 17 that in November 2016, after he received his seasonal influenza vaccine, he sustained a 'red rash all over my body" for approx. 3 days which dissipated without complications. He did not seek medical attention at the time. He had no previous history of similar reaction to that or any other vaccine to his knowledge.
Left arm red/swollen evening of 10/16/02. By next day, diffuse arthralgias bilateral arms, hands, knees, hips, jaw. Not red at site of injection. No fever, rash and petiache.
I have a lasting ache in my left arm and is the reason for the ER visit. The doctors looked at everything and said that I was fine.
Narrative:  85 year old male, received first dose of COVID-19 vaccine on 1/15/2021. PMH: HTN, HLD, hypothyroid, lumbar spinal stenosis, RLS, gout, TIA, depression, CABG x3, CHF. Patient reported tripping and hitting his arm 1/22/2021, requested referral to assisted living facility due to decline in functions of daily living. Multiple calls to agency from patient's sister about increasing dizziness, LE edema and SOB. Patient expired 2/13/2021.
The pt subsequently experienced shakiness, weakness, general achiness and head pressure. Follow up information receoved 7/25/00 indicated that the patient recovered.